BAYER AG
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-12-28
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Bayer
- Target Recruit Count
- 70
- Registration Number
- NCT05171387
- Locations
- 🇨🇳
Many Locations, Multiple Locations, China
A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)
- First Posted Date
- 2021-12-09
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 5737
- Registration Number
- NCT05150938
- Locations
- 🇸🇪
Swedish registries, Multiple Locations, Many Locations, Sweden
A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Bayer
- Target Recruit Count
- 960
- Registration Number
- NCT05149131
- Locations
- 🇨🇦
Databases, Multiple Locations, Alberta, Canada
A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood
- Conditions
- Interventions
- First Posted Date
- 2021-12-07
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Bayer
- Target Recruit Count
- 33
- Registration Number
- NCT05147662
- Locations
- 🇮🇹
Ospedale Pediatrico Bambino Gesù - Oncoematologia, Trapianto Emopoietico e Terapie Cellulari, Roma (RM), Lazio, Italy
🇺🇸Arnold Palmer Hospital for Children, Orlando, Florida, United States
🇦🇷Hospital de Niños Sor María Ludovica, La Plata, Buenos Aires, Argentina
A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)
- Conditions
- Interventions
- First Posted Date
- 2021-11-09
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 2601
- Registration Number
- NCT05112666
- Locations
- 🇬🇧
Many locations, Multiple Locations, United Kingdom
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
- Conditions
- Interventions
- First Posted Date
- 2021-10-29
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Bayer
- Target Recruit Count
- 370
- Registration Number
- NCT05099172
- Locations
- 🇨🇳
Fujian Cancer Hospital, Fuzhou, Fujian, China
🇰🇷Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
🇺🇸Emory University, Atlanta, Georgia, United States
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)
- Conditions
- Interventions
- First Posted Date
- 2021-10-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Bayer
- Target Recruit Count
- 400
- Registration Number
- NCT05099159
- Locations
- 🇺🇸
Unified Women's Clinical Research - Raleigh, Raleigh, North Carolina, United States
🇺🇸Clinical Research of West Florida, Inc., Clearwater, Florida, United States
🇺🇸Metro Jackson OB-GYN, Jackson, Mississippi, United States
A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally
- Conditions
- Interventions
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Bayer
- Target Recruit Count
- 2019
- Registration Number
- NCT05098938
- Locations
- 🇺🇸
Science 37, Culver City, California, United States
A Study in Healthy Adult Male Participants to Learn the Way Vericiguat is Absorbed With and Without Food When Taken as a Single Dose in Liquid Form Suitable for Children Compared to a 10 Milligram (mg) Tablet That Releases the Active Substance Immediately
- First Posted Date
- 2021-10-21
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- Bayer
- Target Recruit Count
- 36
- Registration Number
- NCT05086952
- Locations
- 🇩🇪
SocraTec R&D GmbH, Erfurt, Thüringen, Germany
A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally
- Conditions
- Interventions
- First Posted Date
- 2021-10-08
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Bayer
- Target Recruit Count
- 31
- Registration Number
- NCT05071729
- Locations
- 🇺🇸
Clinical Pharmacology of Miami, LLC, Miami, Florida, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States